Strategies for serum chemokine/cytokine assessment as biomarkers of therapeutic response in HCV patients as a prototype to monitor immunotherapy of infectious diseases
Author:
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq
Fundação Oswaldo Cruz
Fundação de Amparo à Pesquisa de Minas Gerais (FAPEMIG
Publisher
Elsevier BV
Subject
Virology,Pharmacology
Reference31 articles.
1. Relative importance of hepatitis B and C Viruses in hepatocellular carcinoma in EMRO countries and the Middle East: a systematic review;Alavian;Hepat. Mon.,2016
2. Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C;Araújo;Immunol. Lett.,2013
3. A 13-year retrospective study on primary liver cancer in Cambodia: a strikingly high hepatitis C occurrence among hepatocellular carcinoma cases;Chassagne;Oncology,2016
4. Host and viral features in chronic HCV infection: relevance to interferon responsiveness;Craxì;Res. Virol.,1995
5. Targeting the “cytokine storm” for therapeutic benefit;D'Elia;Clin. Vaccine Immunol.,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sarcopenia in chronic viral hepatitis: From concept to clinical relevance;World Journal of Hepatology;2023-05-27
2. Genetic Variants in ITPA and TNFSF10A Are Associated With the Risk of HCV Infection Among Egyptian populations;Egyptian Journal of Chemistry;2022-11-14
3. Circulating macrophage inflammatory protein-1β/IL-12p40 ratio predicts sofosbuvir-based treatment outcome in HCV- genotype 4 patients;Human Antibodies;2021-11-22
4. Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy;Antiviral Research;2021-06
5. Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection;BMC Infectious Diseases;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3